New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

American Heart Association Invites Oral Presentation on Pantethine Study

Researchers from the University of Minnesota will conduct an oral presentation on their recent human clinical trial using Pantesin®. The presentation will be made during the American Heart Association's Scientific Session on Nutrition and Cardiovascular Diseases, to be held November 8 at the Ernest N. Morial Convention Center in New Orleans.

Pantesin® is a high quality pharmaceutical grade form of pantethine sold exclusive by Daiichi Fine Chemicals, Inc.

The study, led by Joe Keenan, M.D. and Joel J. Pins, is entitled “Pantethine beneficially affects apolipoprotein A-1, apolipoprotein B, low density lipoprotein particle size but not high-sensitivity C-Reactive protein in a dyslipidemic population.”

For more information, visit

Sarah Clark
(612) 798-7260

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.